Dead assays refer to experimental tests or procedures that have been discontinued or are no longer considered effective in cancer research. These assays may have been replaced by more advanced or accurate methods. In the context of cancer, dead assays often involve outdated techniques that fail to provide reliable data, are less sensitive, or have been surpassed by newer technologies.
